Identification of STAG1 as a key mediator of a p53-dependent apoptotic pathway
- 13 September 2004
- journal article
- Published by Springer Nature in Oncogene
- Vol. 23 (46) , 7621-7627
- https://doi.org/10.1038/sj.onc.1207270
Abstract
A mutant version of p53 (p53-121F), in which phenylalanine replaces the 121st serine residue, can induce apoptosis more effectively than wild-type p53 (wt-p53). In view of this observation, we considered that one or more apoptosis-related p53-target genes might be preferentially induced by p53-121F. We carried out cDNA microarray analysis to identify such genes, using mRNAs isolated from LS174T colon-cancer cells infected by adenovirus vectors containing either p53-121F (Ad-p53-121F) or wt-p53 (Ad-p53). The STAG1 gene was one of the transcripts showing higher expression levels in cells infected with Ad-p53-121F as opposed to Ad-wtp53. The encoded product appears to contain a transmembrane domain, and binding motifs for SH3 and WW. In two other cancer cell lines, the expression of STAG1 mRNA was induced in response to various genotoxic stresses in a p53-dependent manner; moreover, enforced expression of STAG1 led to apoptosis in several additional cancer cell lines. Suppression of endogenous STAG1 using the RNA-interference method reduced the apoptotic response, whether induced by Ad-p53-121F or Ad-p53. These results suggest that STAG1, a novel transcriptional target for p53, mediates p53-dependent apoptosis, and might be a good candidate for next-generation gene therapy.Keywords
This publication has 22 references indexed in Scilit:
- Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53Oncogene, 2002
- Identification of Developmentally Expressed Proteins That Functionally Interact with Nedd4 Ubiquitin LigaseJournal of Biological Chemistry, 2002
- Increased apoptosis induction by 121F mutant p53The EMBO Journal, 1999
- A Phase I/II Study of Hepatic Artery Infusion with wtp53-CMV-Ad in Metastatic Malignant Liver TumoursHuman Gene Therapy, 1999
- Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.Nature Medicine, 1996
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesCell, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- p53 Mutations in Human CancersScience, 1991
- A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5Virology, 1988